MAGISTRONI, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 7.745
EU - Europa 4.495
AS - Asia 1.269
SA - Sud America 59
AF - Africa 22
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 13.615
Nazione #
US - Stati Uniti d'America 7.707
IT - Italia 1.342
GB - Regno Unito 895
DE - Germania 776
SE - Svezia 591
CN - Cina 392
HK - Hong Kong 301
SG - Singapore 217
UA - Ucraina 205
FI - Finlandia 148
FR - Francia 120
TR - Turchia 120
RU - Federazione Russa 112
BG - Bulgaria 108
IN - India 56
ID - Indonesia 44
AR - Argentina 32
CA - Canada 29
IE - Irlanda 25
CZ - Repubblica Ceca 23
VN - Vietnam 23
ES - Italia 19
IR - Iran 18
NL - Olanda 18
LT - Lituania 17
JP - Giappone 16
BE - Belgio 15
MY - Malesia 14
RO - Romania 14
AU - Australia 13
KR - Corea 12
SI - Slovenia 10
BR - Brasile 9
CH - Svizzera 9
IL - Israele 9
PH - Filippine 9
DK - Danimarca 8
EU - Europa 8
MX - Messico 7
AT - Austria 6
CL - Cile 6
TW - Taiwan 6
BD - Bangladesh 5
CO - Colombia 5
GR - Grecia 5
AZ - Azerbaigian 4
HR - Croazia 4
MA - Marocco 4
MT - Malta 4
NG - Nigeria 4
PE - Perù 4
PK - Pakistan 4
TH - Thailandia 4
TN - Tunisia 4
AL - Albania 3
EE - Estonia 3
IQ - Iraq 3
MD - Moldavia 3
NO - Norvegia 3
PT - Portogallo 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
JO - Giordania 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TJ - Tagikistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
PA - Panama 1
SM - San Marino 1
Totale 13.615
Città #
Fairfield 1.169
Ashburn 772
Chandler 721
Southend 699
Woodbridge 632
Houston 535
Seattle 437
Wilmington 426
Nyköping 421
Cambridge 376
Jacksonville 354
Hong Kong 287
Ann Arbor 285
Dearborn 250
Modena 215
Singapore 156
Beijing 139
San Diego 117
Sofia 108
Princeton 106
Helsinki 90
New York 84
Milan 70
Eugene 69
Redwood City 66
London 55
Izmir 47
Bologna 43
Des Moines 43
Jakarta 40
Rome 39
Shanghai 34
Buenos Aires 31
Parma 31
Falls Church 26
Fremont 25
Boardman 24
Bremen 21
Norwalk 21
Dublin 18
Nanjing 18
Kilburn 15
Leawood 15
Napoli 15
Perugia 15
San Mateo 15
Bari 14
Brno 14
Brussels 14
Naples 14
Phoenix 14
Dong Ket 13
Genoa 13
Andover 11
Munich 11
Paris 11
Turin 11
Carpi 10
Dallas 10
Palermo 10
Tokyo 10
Guangzhou 9
Hefei 9
Hounslow 9
Rimini 9
Augusta 8
Bomporto 8
Brescia 8
Central District 8
Hanoi 8
Los Angeles 8
Reggio Emilia 8
Verona 8
Catania 7
Chennai 7
Monza 7
Mumbai 7
Ottawa 7
Toronto 7
Torre Del Greco 7
Washington 7
Wuhan 7
Chengdu 6
Chiswick 6
Dongguan 6
Ferrara 6
Florence 6
Formigine 6
Jinan 6
Kunming 6
Padova 6
Piacenza 6
Pisa 6
San Francisco 6
Valencia 6
Auburn Hills 5
Carosino 5
Cologne 5
Faenza 5
Lappeenranta 5
Totale 9.621
Nome #
Approccio pratico alla terapia del paziente affetto da Rene Policistico Autosomico Dominante 269
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 249
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 246
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 243
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 235
The definition of chronic kidney disease in a context of aging population 234
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 222
Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study 217
Corticosteroids in IgA nephropathy: A retrospective analysis from the VALIGA study 215
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy 209
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 209
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy? 199
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report. 198
Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment 194
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy 194
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 194
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 192
Tolvaptan in patients with autosomal dominant polycystic kidney disease 187
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 185
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 184
A pilot study to evaluate Tolerability and Safety of a Modified Atkins Diet in ADPKD patients 181
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 180
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 179
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 171
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 170
Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease 166
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis 165
Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study 164
Genome-wide association study identifies susceptibility loci for IgA nephropathy 163
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 163
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine 163
Comment on the paper: 'novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease' 161
Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis 160
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 160
Hypokalemia in Patients with COVID-19 160
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 159
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy 158
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 158
Trattato di Medicina Interna : Le Sindromi Renali. 155
Advances in genetics of Immunoglobulin A Nephropathy. 155
Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging 150
Defective glycolysis and the use of 2-deoxy-d-glucose in polycystic kidney disease: from animal models to humans 147
Geometry-independent assessment of renal volume in polycystic kidney disease from magnetic resonance imaging 142
Unified criteria for ultrasonographic diagnosis of ADPKD 141
The MEST score provides earlier risk prediction in lgA nephropathy 141
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens 140
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 140
Il Registro Italiano del Rene PolicisticoAutosomico Dominante 134
Interstitiome: a novel proteomic discipline applied to renal biopsy 130
Autosomal dominant polycystic kidney disease: from genes to cilium. 127
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36 127
Peritoneal dialysis in the time of coronavirus disease 2019 126
Genetic variation of DKK3 may modify renal disease severity in ADPKD 123
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 123
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 122
A validated model of disease progression in IgA nephropathy 121
Evaluation of coronary artery disease by multislice spiral computed tomography in dialysis patients 119
Urine Proteome Analysis May Allow Non-Invasive Differential Diagnosis of Diabetic Nephropathy 116
Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. 114
ADPKD current management and ongoing trials 113
MALATTIE DEL RENE, DELLE VIE URINARIE E DELL'APPARATO GENITALE MASCHILE : Le Nefropatie Glomerulari: glomerulonefriti primitive; glomerulonefriti secondarie 112
Clinical diagnosis of Autosomal Dominant Polycystic Kidney Disease 109
HEMOREOLOGIC PROFILE OF KIDNEY TRANSPLANT RECIPIENTS: A ROLE IN CARDIOVASCULAR RISK? 108
Acid base disorders in patients with COVID-19 103
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 102
Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease 101
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 98
Long-term effects of COVID-19 in a patient on maintenance dialysis 95
One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19 91
Methicillin-Resistant Staphylococcus aureus Peritonitis due to Hematogenous Dissemination from Central Venous Catheter in a Maintenance Dialysis Patient 89
The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection 85
Hybrid dialysis: A promising strategy to reduce hospital access during the SARS-CoV-2 pandemic 84
Monoclonal antibodies in nephrology: a delicate balance between curative potential, evidence of effectiveness, and toxicity 83
Response letter to the Editorial: "Ketogenic diet in ADPKD patients" 83
[Screening for cerebral aneurysms in the ADPKD population: mandatory or potentially harmful?] 82
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 82
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 81
Towards evidence-based nephrology: the seeming paradox of "out-of-line" guidelines. 80
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 78
Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease 78
Erratum: The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection (Journal of Physical Chemistry DOI: 10.1159/000507914) 77
The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review 76
HEMORHEOLOGY IN RENAL TRANSPLANTATION 75
[Genetics and genetic counseling] 74
SARS-CoV-2 infection in dialysis patients in northern Italy: A single-centre experience 74
Insufficienza renale gestione della uremia e della terapia sostitutiva 73
[Diagnosis in Polycystic Kidney Disease] 73
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy 73
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 68
AKI in hospitalized patients with COVID-19: a single-center experience 65
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes 64
Monoclonal B lymphocytosis in a kidney transplant recipient 64
A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression 63
Erratum: SARS-CoV-2 infection in dialysis patients in northern Italy: A single-centre experience (Clinical Kidney Journal (2020) 13:3 (334-339) DOI: 10.1093/ckj/sfaa084) 62
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 61
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants 61
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 58
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 58
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 50
Artificial intelligence in glomerular diseases 49
Totale 13.304
Categoria #
all - tutte 65.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.045 0 146 83 130 219 344 331 205 225 94 155 113
2020/20212.628 189 136 211 189 248 255 230 294 132 351 255 138
2021/20222.342 180 206 223 166 100 131 130 138 260 189 371 248
2022/20232.439 234 247 209 211 215 332 95 249 258 57 142 190
2023/20241.848 101 113 127 227 280 174 179 227 56 64 105 195
2024/2025210 148 62 0 0 0 0 0 0 0 0 0 0
Totale 13.913